Duncker Streett & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.86M | Sell |
20,054
-4,735
| -19% | -$2.57M | 1.87% | 12 |
|
|
2025
Q4 | $14.4M | Buy |
24,789
+3,218
| +15% | +$1.82M | 2.55% | 9 |
|
|
2025
Q3 | $10.5M | Sell |
21,571
-864
| -4% | -$402K | 1.82% | 12 |
|
|
2025
Q2 | $9.1M | Sell |
22,435
-1,750
| -7% | -$732K | 1.66% | 14 |
|
|
2025
Q1 | $12M | Sell |
24,185
-554
| -2% | -$300K | 2.38% | 8 |
|
|
2024
Q4 | $12.9M | Sell |
24,739
-232
| -0.9% | -$128K | 2.39% | 8 |
|
|
2024
Q3 | $15.4M | Sell |
24,971
-212
| -0.8% | -$125K | 2.82% | 5 |
|
|
2024
Q2 | $13.9M | Sell |
25,183
-1,059
| -4% | -$607K | 2.68% | 7 |
|
|
2024
Q1 | $15.3M | Sell |
26,242
-164
| -0.6% | -$92K | 3.01% | 4 |
|
|
2023
Q4 | $14M | Sell |
26,406
-57
| -0.2% | -$27.6K | 2.96% | 4 |
|
|
2023
Q3 | $13.4M | Buy |
26,463
+242
| +0.9% | +$129K | 3.12% | 5 |
|
|
2023
Q2 | $13.7M | Sell |
26,221
-107
| -0.4% | -$57.7K | 3.06% | 5 |
|
|
2023
Q1 | $15.2M | Sell |
26,328
-68
| -0.3% | -$38.3K | 3.61% | 1 |
|
|
2022
Q4 | $14.5M | Sell |
26,396
-973
| -4% | -$516K | 3.51% | 2 |
|
|
2022
Q3 | $13.9M | Sell |
27,369
-330
| -1% | -$185K | 3.6% | 2 |
|
|
2022
Q2 | $15M | Sell |
27,699
-308
| -1% | -$170K | 3.61% | 2 |
|
|
2022
Q1 | $16.5M | Sell |
28,007
-1,209
| -4% | -$695K | 3.29% | 4 |
|
|
2021
Q4 | $19.5M | Sell |
29,216
-238
| -0.8% | -$149K | 3.36% | 2 |
|
|
2021
Q3 | $16.8M | Sell |
29,454
-552
| -2% | -$303K | 3.19% | 2 |
|
|
2021
Q2 | $15.1M | Sell |
30,006
-894
| -3% | -$422K | 2.79% | 4 |
|
|
2021
Q1 | $14.1M | Buy |
30,900
+396
| +1% | +$189K | 2.69% | 4 |
|
|
2020
Q4 | $14.2M | Sell |
30,504
-424
| -1% | -$199K | 2.75% | 5 |
|
|
2020
Q3 | $13.7M | Sell |
30,928
-50
| -0.2% | -$20.7K | 2.98% | 4 |
|
|
2020
Q2 | $11.2M | Sell |
30,978
-1,111
| -3% | -$372K | 2.67% | 5 |
|
|
2020
Q1 | $9.1M | Sell |
32,089
-674
| -2% | -$213K | 2.43% | 4 |
|
|
2019
Q4 | $10.6M | Sell |
32,763
-813
| -2% | -$247K | 2.23% | 4 |
|
|
2019
Q3 | $9.78M | Buy |
33,576
+37
| +0.1% | +$10.6K | 2.27% | 4 |
|
|
2019
Q2 | $9.85M | Sell |
33,539
-1,374
| -4% | -$378K | 2.21% | 5 |
|
|
2019
Q1 | $9.56M | Buy |
34,913
+1,414
| +4% | +$352K | 2.2% | 5 |
|
|
2018
Q4 | $7.5M | Sell |
33,499
-278
| -0.8% | -$65.2K | 2.01% | 5 |
|
|
2018
Q3 | $8.24M | Buy |
33,777
+462
| +1% | +$106K | 1.87% | 5 |
|
|
2018
Q2 | $6.9M | Hold |
33,315
| – | – | 1.71% | 6 |
|
|
2018
Q1 | $6.88M | Buy |
33,315
+4,073
| +14% | +$855K | 1.74% | 6 |
|
|
2017
Q4 | $5.55M | Sell |
29,242
-130
| -0.4% | -$24.9K | 1.43% | 8 |
|
|
2017
Q3 | $5.56M | Sell |
29,372
-400
| -1% | -$72.4K | 1.68% | 6 |
|
|
2017
Q2 | $5.2M | Sell |
29,772
-209
| -0.7% | -$35.1K | 1.62% | 5 |
|
|
2017
Q1 | $4.61M | Sell |
29,981
-2,650
| -8% | -$405K | 1.44% | 7 |
|
|
2016
Q4 | $4.61M | Buy |
32,631
+405
| +1% | +$59.7K | 1.53% | 6 |
|
|
2016
Q3 | $5.13M | Buy |
32,226
+200
| +0.6% | +$30.8K | 1.78% | 4 |
|
|
2016
Q2 | $4.73M | Sell |
32,026
-250
| -0.8% | -$36.9K | 1.68% | 4 |
|
|
2016
Q1 | $4.57M | Sell |
32,276
-1,171
| -4% | -$157K | 1.69% | 5 |
|
|
2015
Q4 | $4.75M | Sell |
33,447
-535
| -2% | -$71.4K | 1.78% | 5 |
|
|
2015
Q3 | $4.16M | Sell |
33,982
-800
| -2% | -$104K | 1.62% | 6 |
|
|
2015
Q2 | $4.51M | Sell |
34,782
-3,900
| -10% | -$508K | 1.57% | 6 |
|
|
2015
Q1 | $5.2M | Sell |
38,682
-250
| -0.6% | -$32.2K | 1.7% | 5 |
|
|
2014
Q4 | $4.88M | Hold |
38,932
| – | – | 1.6% | 5 |
|
|
2014
Q3 | $4.74M | Sell |
38,932
-3,423
| -8% | -$416K | 1.62% | 6 |
|
|
2014
Q2 | $5M | Buy |
42,355
+1,541
| +4% | +$181K | 1.62% | 5 |
|
|
2014
Q1 | $4.91M | Sell |
40,814
-200
| -0.5% | -$23.8K | 1.74% | 5 |
|
|
2013
Q4 | $4.57M | Hold |
41,014
| – | – | 1.64% | 6 |
|
|
2013
Q3 | $3.78M | Sell |
41,014
-3,066
| -7% | -$277K | 1.53% | 8 |
|
|
2013
Q2 | $3.73M | Buy |
+44,080
| New | +$3.67M | 1.43% | 8 |
|
Other funds holding TMO
VCM
Duncker Streett & Co's TMO Position: Q1 2026 in Review
Duncker Streett & Co reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $2.57M and leaving 20,054 shares worth $9.86M. The position accounts for 1.87% of the portfolio, ranked #12.
Duncker Streett & Co first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.5M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Duncker Streett & Co held 20,054 shares of Thermo Fisher Scientific worth $9.86M as of Q1 2026.
- Duncker Streett & Co sold 4,735 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.57M.
- Thermo Fisher Scientific made up 1.87% of Duncker Streett & Co's portfolio in Q1 2026, its #12 holding.
- Duncker Streett & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Duncker Streett & Co's Thermo Fisher Scientific position peaked at $19.5M in Q4 2021.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.